Bone Scanning: The Current Position

Berg G. R. Kalisher L. Osmond J. D. Pendergrass H. P. Potsaid M.S. (1973). ⁹⁹mTc-Diphosphonate concentration in primary breast carcinoma. Radiology, 109, 393

Citrin D. L. Bessent R. G. Greig W. R. Lindsay M.K. Rogers J. (1974a). Pharmacological studies with 99mTc labelled polyphosphate, pyrophosphate and E.H.D.P. in patients and normal subjects. British Nuclear Medicine Society, March, London

Citrin D. L. Bessent R. G. Tuohy J. B. Greig W. R. Blumgart L. H. (1974b). Quantitative bone scanning: A method for assessing response of bone metases to treatment. Lancet, 1, 1132

Edeiken J. (1972). Radiologic approach to diagnosis of bone disease, clinical uses of radionuclides: Critical comparison with other techniques. Editors: Goswitz F. A. Andres G. A. Viamont M. K. U.S.A.E.C. 27, pp 90–100.

McDougall I. R. Pistenma D.A. (1974). Concentration of 99mTc-diphosphonate in breast tissue. Radiology, 112, 655

Pistenma D. A. McDougall I. R. Kriss J. P. (1974). Screening for bone metastases, are only scans necessary? Journal of the American Medical Association, in press

Subramanian G. McAfee J. G. (1971). A new complex of ⁹⁹mTc for skeletal imaging. Radiology, 99, 192